Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

The physiological basis of intracrine stem cell regulation

Re RN., Cook JL.

Narrative Review on Cardiovascular Disease, published in Am J Physiol Heart Circ Physiol (2008) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Am J Physiol Heart Circ Physiol (2008)
Reported sample size
—
Source database
Europe PMC
PMID
18552159
PMCID
PMC2519209
DOI
10.1152/ajpheart.00461.2008
Citations
12

Abstract (original English)

Intracrine peptides and proteins participate in the regulation of adult and pleuripotential embryonic-like stem cells. Included among these factors are VEGF, dynorphin, the readthrough form of acetylcholinesterase, Oct3/4, Pdx-1, Pax-6, and high-mobility group protein B1, among others. In some cases, the establishment of intracrine feedback loops can be shown to be relevant to this regulation, consistent with previously proposed principles of intracrine action. Here the role of intracrines in stem cell regulation is reviewed, with particular attention to the intracrine regulation of cardiac stem cells. The reprogramming of cells to restore the pleuripotent phenotype and the possible role of stem/progenitor cells in neoplasia are also discussed.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Myocytes, CardiacStem CellsPluripotent Stem CellsAnimalsHumansIntracellular Signaling Peptides and ProteinsDNA-Binding ProteinsHomeodomain ProteinsTranscription FactorsSignal Transduction

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research